Business
The deal is expected to close in January 2023.
According to TechCrunch and Fierce Healthcare, the health data company also recently closed a $200 million structured equity infusion.
The companies also raised $13 million in funding to support the merger.
The tool embeds in the EHR and allows providers to write care workflows that deliver best practices and next steps.
The company will use the investment to expand its technology's current abilities, add capabilities to detect additional health conditions and drive global growth.
Earlier this year, the company received FDA clearance for its RPM system that collects data like skin temperature, auscultation and heart rate in the home.
Though funding has fallen this year, Dr. Sunny Kumar, partner at GSR Ventures, said there are still opportunities for startups that can prove their value.
The startup has set up a subsidiary in New York using the proceeds from its first Series C round.
The company said it will use the capital to hire for its commercial teams and advance development on new features.
The company said it needed to restructure following "a period of rapid growth and hiring."